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Abstract
Most processes involving an organism’s genetic material, including replication, repair and
recombination, require access to single stranded DNA as a template or reaction intermediate. To
disrupt the hydrogen bonds between the two strands in double stranded DNA, organisms utilize
proteins called DNA helicases. DNA helicases use duplex DNA as a substrate to create single
stranded DNA in a reaction that requires ATP hydrolysis. Due to their critical role in cellular function,
understanding the reaction catalyzed by helicases is essential to understanding DNA metabolism.
Helicases are also important in many disease processes due to their role in DNA maintenance and
replication. Here we discuss ways to rapidly purify helicases in sufficient quantity for biochemical
analysis. We also briefly discuss potential substrates to use with helicases to establish some of their
critical biochemical parameters. Through the use of methods that simplify the study of helicases, our
understanding of these essential proteins can be accelerated.
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INTRODUCTION
The double-stranded structure of DNA provides for an elegant mechanism to ensure accurate
and faithful replication and repair of the DNA – the genetic information stored in one strand
is also encoded in its complement. To take advantage of the properties of complementary base
pairing, the two strands of the double helix must be separated or unwound to provide DNA
polymerases, strand transferases, primases, RNA polymerases, and other proteins with access
to single-stranded DNA (ssDNA). Enzymes able to catalyze the unwinding of double-stranded
DNA (dsDNA) were first discovered over three decades ago [1,2]. Referred to as DNA
helicases, these enzymes disrupt the hydrogen bonds that hold the two strands of duplex DNA
together to generate, at least transiently, the ssDNA required as a template or reaction
intermediate in the various aspects of DNA metabolism [3,4].
Studies conducted during the last 30 years have demonstrated that DNA helicases are
ubiquitous in nature. Indeed, a multitude of distinct helicases have now been identified and
characterized [5,6]. Genetic studies have been useful in determining that DNA helicases are
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involved in every aspect of DNA metabolism. Specific helicases are required in DNA
replication, in DNA repair, in recombination and in bacterial conjugation. A similar but distinct
class of enzymes called RNA helicases serves an analogous role in processes involving RNA
including transcription, translation and RNA processing [7–13]. Thus, helicases are involved
in all aspects of nucleic acid metabolism and, as such, play a central role in promoting and
controlling growth and duplication of the cell.
It is also clear that each cell contains multiple distinct helicases. For example, the bacterium
Escherichia coli (E. coli) contain at least 11 DNA helicases [4,14,15]. Even the relatively
simple bacteriophage T4 encodes (at least) two different DNA helicases [16]. Genetic and
biochemical studies have revealed that each DNA helicase has a role in a specific pathway in
the cell [4]. Presumably, each helicase makes specific protein-DNA and protein-protein
contacts that direct it to the appropriate DNA substrate in the appropriate reaction pathway.
For example, the DnaB protein in E. coli is the primary replicative helicase in the cell [17]. No
other helicase found in E. coli can substitute for DnaB protein in this capacity. Similarly, DNA
helicase II is involved in UvrABC-mediated excision repair of pyrimidine dimers [18] and
methyl-directed mismatch repair [19], and no other helicase in the cell can substitute for
helicase II in these roles [20]. Thus, it seems likely that the variety of DNA helicases found in
the cell has evolved to provide helicase function in specific reaction pathways.
Although a great deal has been learned regarding the essential roles of DNA helicases in DNA
metabolism, less is known regarding the mechanism of helicase-catalyzed duplex DNA
unwinding. All helicases catalyze a DNA-stimulated hydrolysis of nucleoside 5′-triphosphates
(NTPs), usually ATP. The energy liberated upon hydrolysis of the high energy phosphate bond
between the beta and gamma phosphates is required for DNA unwinding. Precisely how the
energy-providing ATPase activity and the energy-requiring helicase activity are coupled is an
active area of investigation. It has been suggested that hydrolysis of the nucleotide serves to
cycle the enzyme through conformational states with differing affinities for dsDNA and ssDNA
[21,22]. It has also been proposed that most helicases function as multimers, either dimers or
hexamers [5,21]. This arrangement provides for multiple DNA binding sites as well as multiple
NTP binding sites on the active form of the enzyme. Two general mechanisms for DNA
unwinding have been advanced; a passive mechanism and an active mechanism [21,23]. The
passive mechanism relies on thermal breathing of the duplex at the junction of ssDNA and
dsDNA with the helicase passively occupying the thermally denatured region and preventing
it from reannealing. The active mechanism, on the other hand, requires the helicase to actively
disrupt the hydrogen bonds holding the duplex together. Helicases that are carefully examined
to date appear to catalyze unwinding by the latter, active mechanism [24]. Lohman and
colleagues have proposed a rolling model to account for unwinding by the E. coli Rep protein
dimer [22]. In this model each Rep monomer (protomer) alternates between binding duplex
DNA at the ssDNA-dsDNA junction and binding ssDNA just behind the ssDNA-dsDNA
junction. Upon ATP hydrolysis the enzyme unwinds the duplex region to render it single-
stranded leaving both protomers bound to ssDNA. The protomer originally bound to ssDNA
then moves relative to the other protomer to occupy the region of duplex DNA at the ssDNA-
dsDNA junction and the process is repeated. Thus, the enzyme can be envisioned to roll into
and unwind the duplex region. A thorough review of the recent literature on helicase unwinding
reaction mechanism has recently appeared [5] and we will not consider this topic further.
However, it should be noted that this mechanism has not been rigorously proved although
compelling evidence, obtained using the E. coli Rep helicase, has been obtained in support of
this model. It is possible that other helicases unwind duplex DNA by other mechanisms.
Specifically, the mechanism utilized by hexameric helicases remains unknown, although
significant work in this area has appeared recently [25]. This represents an active and exciting
area of continuing investigation.
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It should also be noted that each helicase appears to unwind duplex DNA with a specific polarity
defined with respect to the strand of DNA on which the protein is presumed to be primarily
bound. Unwinding polarity is empirically determined using a linear DNA substrate with a large
region of ssDNA in the middle and duplex regions of differing lengths on each end. Since most
helicases appear to bind and preferentially initiate unwinding from a ssDNA region, the enzyme
is presumed to bind the ssDNA and then move toward one end of the linear DNA. Alternatively,
the enzyme could bind preferentially to one or the other of the two available ssDNA-dsDNA
junctions. In either case, one of the two duplex regions is preferentially unwound and this event
is used to operationally define the macroscopic polarity of the unwinding reaction. Presumably
the polarity of unwinding has relevance to the biological role of the enzyme although this has
yet to be rigorously tested.
Interest in fully understanding this class of proteins has been heightened by the discovery that
mutations in specific DNA helicases result in human genetic diseases [26–28]. For example,
Xeroderma pigmentosum, a disease resulting in severe sensitivity to sunlight and the
occurrence of skin cancer, results from a defect in the DNA excision repair pathway in human
cells. Seven complementation groups have been identified; two encode DNA helicases [29–
32]. The gene responsible for Bloom’s syndrome (BLM) was identified as a DNA helicase
[33,34] and patients with Bloom’s syndrome are predisposed to several different classes of
neoplasm suggesting that this gene product plays a fundamental role in an important aspect of
DNA metabolism that, when defective, leads to cancer in a wide range of tissues [35]. The
Werner’s syndrome gene (WRN) has also been shown to encode a DNA helicase/exonuclease
[36]. Patients with Werner’s syndrome appear to age prematurely [37,38] suggesting that this
gene product plays a fundamental role in nucleic acid metabolism. As a final example, the gene
encoding another human RecQ helicase family member, RecQL4, is linked to Rothman-
Thomson syndrome [39,40]. There is no doubt that other diseases will be linked with defects
in DNA helicases as more disease genes are identified. This places added emphasis on the
importance of understanding this class of proteins.
Fully understanding the mechanism and role played by any helicase in the cell requires that
the protein be purified to near homogeneity for biochemical study. This requires cloning of the
gene encoding the protein in an appropriate expressions system followed by purification. Here
we describe an E. coli expression system that allows rapid purification through the use of
affinity tags. This system has proven useful for the routine purification of several helicases
including eukaryotic helicases and large helicase proteins.
RAPID HELICASE PURIFICATION
Most proteins benefit from rapid purification which reduces susceptibility to proteolysis and
denaturation. Affinity tags offer several advantages in rapid purification strategies but have
limitations of their own. Though some tags, such as a poly-histidine (His-tag) or a HA-tag, are
quite small and comprise of only a few amino acids they still raise the question of what effect
those few extra amino acids have on the native activity of the protein. Because of this limitation
we have modified the Impact System (New England Biolabs, Ipswich MA) which allows
removal of the affinity tag in the last purification step and utilized this modification for rapid
purification of helicase proteins. The pTYB4 plasmid contains a C-terminal tag that consists
of an intein fused to a chitin binding domain (intein-CBD). The CBD is able to bind a chitin
column very efficiently in the presence of high salt and, in a reducing environment (50 mM
DTT), the intein cleaves itself from the C-terminus of the protein leaving only one or two extra
amino acids depending on the cloning procedure. This tag system is very effective for rapid
protein purification, but it is rare to achieve greater than 90% homogeneity with a single
column.
Tahmaseb and Matson Page 3













To achieve the purity required for biochemical analysis, we modified the pTYB4 plasmid by
adding an eight-histidine tag on the C-terminus of the CBD (Fig 1). The his-tag was introduced
into the plasmid via polymerase chain reaction (PCR) using the pTYB4 plasmid as template.
The forward primer for this PCR was 5′-GGAATTGTGAGCGGATAACAATTCCCC-3′ and
the reverse primer, containing the sequence for the histidine tag (underlined), was 5′-
AATCTGCAGTCAGTGATGGTGATGGTGATGGTGATG
TTGAAGCTGCCACAAGGC-3′. The PCR product and the original pTYB4 vector were
digested with HindIII and PstI, and the PCR product was ligated into pTYB4 to create the new
plasmid, pTYB4-His. The addition of the His-tag to pTYB4 allows for a rapid and efficient
two-column purification that yields nearly homogeneous protein in a procedure that takes as
little as a single day without the permanent addition of a tag to the protein of interest. Using
this expression plasmid we have found that we get very efficient enrichment of the histidine-
tagged fusion protein using cobalt based affinity columns such as TALON® (Clontech,
Mountain View CA). We do not expect any problems with the use of a nickel based affinity
column for this step in the procedure.
In figure 2a we have delineated the basic purification protocol using the pTYB4-His expression
plasmid. Briefly, the cells are lysed and the cleared lysate is passed over a TALON® column
to allow binding of the target protein via the 8-his tag on the fusion protein. The column is
washed extensively to remove unbound proteins, the target protein is eluted with imidazole
and the eluted protein is applied directly to a chitin column. There is no need for a dialysis step
since the high salt and imidazole concentrations do not interfere with binding to the chitin resin.
The target protein is released from the chitin column by incubation with 50 mM DTT to allow
intein-directed cleavage from the tag. The resulting eluted protein is ready for dialysis into
storage buffer. Depending on the length of the incubation with DTT, this procedure can be
completed in as little as 24 hours with excellent results.
A critical issue for effective protein purification using the pTYB4-His system (or any system
for that matter) is the ability to express significant amounts of soluble protein in E. coli. A key
to effective expression in E. coli is determining the appropriate media and temperature for the
specific protein being expressed. Though many proteins are expressed successfully in Luria-
Bertani (LB) media with isopropyl-β-D-thiogalactopyranoside (IPTG) induction at 37 °C,
some proteins – especially large or non-prokaryotic proteins – may require modification of
these conditions for the expression of significant amounts of soluble protein. One means of
increasing the solubility of proteins is by reducing the expression temperature. Cells are grown
to an OD600 of 0.8, IPTG is added, and the induction is carried out either at room temperature
or at 16°C depending on the protein being expressed (Table 1). When the temperature of the
induction incubation is decreased the length of the incubation is increased to as much as 24
hours in some cases. We determine the appropriate length of the induction empirically by
evaluating soluble protein at various time points after the addition of IPTG. If reduction in
temperature is not sufficient then the growth media may be changed. One media that works
particularly well for expressing difficult proteins is the autoinduction media ZYM-5052, as
described in [41]. Autoinductions may also be tried at different temperatures to improve
expression or solubility. Generally the lower the temperature the lower the level of expression,
however, it may also result in greater solubility of the protein being expressed. As with IPTG
inductions, when the temperature of the autoinduction is reduced the length of the incubation
must be increased. Autoinduction at 16°C can require as much as a 40 hour incubation (Table
1).
A good example of a rapid purification involving a large protein is E. coli helicase I (TraI).
TraI is a 192 kDa protein and, with the addition of the intein-CBD-His tag, the size of the
expressed fusion protein is increased to over 250 kDa. We utilized a two step procedure to
clone the traI gene into pTYB4-His due to its large size. The XbaI and SacI fragment of
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pET11c-TraI [42] was removed and ligated into the pTYB4-His digested with the same
enzymes to complete cloning of the first half of the traI gene into pTYB4-His. The second half
of the gene was amplified via PCR using pET11c-TraI as the template and the following primers
5′-CGATGAGAGCTCAATGG-3′ (forward primer) and 5′-GTCTCCACCCAGGGTTTTC-3′
(reverse primer). The reverse primer amplified traI up to and including the last sense codon
but did not include the stop codon so that the C-terminal tag could be fused to the traI gene
allowing expression of the appropriate fusion protein. This PCR product was digested with
SacI and the 3′ end of the amplicon was left blunt; an appropriately phosphorylated primer was
used for this PCR. The pTYB4-His plasmid containing the first half of the traI gene was
digested with SacI and SmaI to facilitate the directional cloning of the PCR amplicon creating
the final desired construct – pTYB4-His-TraI (Fig 1). Alternatively, a SmaI site could be placed
at the 3′ end of the gene being amplified. However, the creation of a full SmaI site in the final
pTYB4-His construct will result in the addition of two extra amino acids at the C-terminus of
the cleaved protein. The procedure used here results in the addition of a single glycine residue
at the C-terminus of the purified protein product.
pTYB4-His-TraI was transformed into chemically competent HMS174 (DE3) cells for
expression of the fusion protein. To increase the solubility of this large protein, cells were
grown and induced using 0.3 mM IPTG at room temperature. Incubation at room temperature
was continued for 16 hours (Table 1). Cells were harvested by centrifugation at 6000 × g for
10 minutes, suspended once using ice cold STE (100 mM NaCl, 10 mM Tris-HCl pH 8, 1 mM
EDTA) and spun down again. The cell pellet was weighed and stored at −70°C until needed
for protein purification.
To purify protein the cell pellet was thawed on ice and resuspended in a volume of lysis buffer
(20 mM Tris-HCl pH 8, 100 mM NaCl, 10% glycerol, and 5 mM imidazole) equivalent to four
times the cell pellet weight. The cells were lysed by the addition of lysozyme to a final
concentration of 250 μg/ml with incubation at 4°C for 30 minutes followed by the addition of
0.05% sodium deoxycholate. Sodium chloride was added slowly to the lysate until the final
salt concentration was at 500 mM. The lysate was sonicated to reduce viscosity and centrifuged
at 21,000 rpm for 1 hour in a Sorvall SS34 rotor to prepare a cleared lysate. The cleared lysate,
shown in figure 2b (lane 2), contains the soluble tagged fusion protein as the major band above
the 200 kDa marker. The identity of the protein was confirmed with Western blotting (data not
shown). Inductions at both 30°C and 37°C failed to produce significant amounts of soluble
fusion protein.
The affinity tagged TraI was batch bound to cobalt affinity resin (TALON®) for 1 hour at 4°
C. The protein-bound resin was then poured into a column and extensively washed with buffer
(20 mM Tris-HCl (pH 8), 500 mM NaCl, 10% glycerol, and 5 mM imidazole) until the residual
protein eluting from the column was less than 10 μg/ml. The TraI-intein-CBD-His fusion
protein was eluted using wash buffer containing 250 mM imidazole. The TALON® elution
was then directly batch bound to chitin beads (New England Biolabs, Ipswich MA) for 1 hour
at 4°C. The protein-resin slurry was poured into a column and washed extensively with chitin
wash buffer (20 mM Tris-HCl (pH 8), 750 mM NaCl, 10% glycerol, and 0.1 mM EDTA) until
the residual protein eluting from the column was less than 10 μg/ml. Ten column volumes of
wash buffer plus 50 mM dithiothreitol (DTT) were passed over the column and the column
was plugged and incubated overnight at 4°C to allow intein-directed cleavage of the affinity
tags from TraI. Purified TraI eluted from the chitin column at greater than 90% purity (Fig 2b,
lane 6). This purification procedure requires a total of 24 hours from cell lysis to purified
protein.
The example of TraI purification described above demonstrates two important advances in the
purification of this protein. First is the successful expression of a very large fusion protein that
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is soluble in E. coli. This required reducing the temperature of induction. The second is that a
purification scheme that used to take several days and multiple columns can now be completed
in one 24 hour period, providing pure protein with high specific activity. We have also purified
E. coli UvrD (unpublished) and S. cerevisiae Hmi1p [43] using this procedure demonstrating
its utility for the purification of eukaryotic helicases.
SUBSTRATES FOR HELICASE ASSAYS
The availability of purified protein allows a detailed analysis of the biochemical activity of the
helicase. There are many suitable assays and substrates available to measure helicase activity
[44–46]. Here we will focus on simple assays that can be used to begin to assess the helicase
activity of the purified protein. More sophisticated analyses are possible and are required to
elucidate mechanism.
The first substrate we describe can be used to initiate the biochemical characterization of a
helicase without prior knowledge of the polarity of unwinding. This substrate, shown in figure
3a, consists of M13 ssDNA to which an oligonucleotide is annealed to create a duplex region.
Here we describe the construction of a substrate with a 93 base pair duplex region. However,
the length of the duplex region can be extended or shortened by appropriate choice of
oligonucleotide. In practice, substrates made with oligonucleotides less than about 25 bases in
length are unstable and can undergo spontaneous melting under helicase assay conditions.
To prepare this substrate M13mp18 or mp19 ssDNA is annealed with a 91 base oligonucleotide
with the sequence 5′-
AGTAGCACCATTACCATTAGCAAGGCCGGAAACGTCACCAATGAAACCATCGAT
AGCAGCACCGTAATCAGTAGCGACAGAATCAAGTTTG-3′ in a 1:1 molar ratio by
mixing ssDNA with the oligonucleotide in annealing buffer (50 mM Tris-HCl (pH 7.5), 10
mM Mg2Cl, 50 mM NaCl) followed by heating to 95°C and slow cooling to room temperature.
The Klenow fragment of E. coli DNA polymerase I is then used to add two [32P]dCMP residues
to the 3′ end of the duplex region to generate the 93 base pair partial duplex substrate (Fig 3a).
In this case, the sequence of the oligonucleotide chosen allows the incorporation of two
contiguous dCMP residues providing a substrate with higher specific activity. Alternatively,
the oligonucleotide can be labeled on the 5′-end using [γ-32P]ATP and polynucleotide kinase.
Because of the circular nature of this substrate, the polarity of the helicase is not a concern.
This substrate can be processed further to study the polarity of a helicase as described below.
An alternative circular substrate with substantial duplex DNA is shown in figure 3b. This DNA
substrate is particularly appropriate for biochemical analysis of processive DNA helicases. To
construct this gapped duplex DNA we start with a plasmid of a desired size since the larger
the plasmid the longer the unwinding tract for the helicase. Here we describe the construction
using the pUC19 plasmid which yields a duplex region approximately 2.7 kbp in length. To
construct a ssDNA gap of defined size we introduced a series of Nt.BbvCI recognition
sequences (5′-CCTCAGC-3′) by cloning an appropriate duplex DNA fragment with multiple
Nt.BbvCI recognition sites into the multiple cloning site in pUC19 using oligonucleotides. The
Nt.BbvCI enzyme will introduce a nick after the second cytosine at each recognition site. The
idea is to introduce several tandem Nt.BbvCI recognition sites, all on the same DNA strand,
to allow the construction of a gapped molecule with a defined length gap. In the example
mentioned we introduced four Nt.BbvCI recognition sites to produce a gap that is 31
nucleotides in length.
To prepare the gapped DNA the plasmid is nicked to completion with Nt.BbvCI and then
denatured at 80°C for 20 minutes to release the small oligonucleotides between each nick site.
The gapped DNA is purified with the use of a PCR purification kit to remove the released
oligonucleotides (Fig 3b). Finally, the DNA substrate is labeled using [α-32P]dCTP and the
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Klenow fragment of DNA Polymerase I. Unwinding of this molecule by a DNA helicase is
evaluated using agarose gels.
Finally, as mentioned above, a modification of the 93 base pair partial duplex substrate shown
in figure 3a can also be used to determine the directionality of a helicase. To modify this
substrate to determine directionality, the 91 base oligonucleotide is annealed to the M13 ssDNA
as described above. Then, prior to labeling with [32P]dCMP, the substrate is digested with
BspDI or ClaI which cleave once in the duplex region to produce a linear DNA with duplex
ends and a long internal region of ssDNA. Cleavage with BspDI or ClaI leaves a 5′-CG
overhang at each end of the linear DNA molecule. The overhangs, along with the 3′-end of the
oligonucleotide annealed to produce the duplex region, can then be filled in or extended using
the Klenow fragment of DNA polymerase I in the presence of dGTP and [α-32P]dCTP to
produce a molecule with a radioactive label on all three of the 3′-ends. The duplex region of
the substrate is cut to produce a 52 bp duplex region at one end of the linear molecule and a
43 bp duplex region at the other end of the linear molecule (Fig 4). This substrate can be used
to assess the directionality of the helicase – if the helicase has 3′ to 5′ directionality it will
displace the 52 base oligonucleotide, and if it has 5′ to 3′ directionality it will displace the 43
base oligonucleotide.
Using these simple DNA substrates it is possible to begin to determine many properties of a
particular helicase. Directionality is a very important property of a helicase to determine.
Furthermore, depending on the processivity of the helicase in question, the small 93 base pair
partial duplex or the large plasmid based gapped substrate can help answer questions regarding
the unwinding parameters of the helicase in question.
SUMMARY
The current dogma that large or eukaryotic proteins cannot be expressed in E. coli is an over
generalization. By experimenting with different media conditions and temperatures we have
successfully expressed and purified several prokaryotic and eukaryotic helicases in E. coli
(Table 1). In addition, the use of the double affinity tag system we describe here has made it
possible to obtain very pure protein quickly, compared to previous methods. The advantage of
obtaining pure protein quickly goes beyond saving time spent on purification protocols, it also
increases the specific activity of the purified protein.
Another significant and unique advantage of this double affinity tag system versus other
systems is that it allows for almost complete removal of the affinity tags without the use of
proteases. In other double affinity tag systems like the TAP tag system, not all tags are removed
and the removal of the first tag requires protease treatment [47]. In our tandem affinity tag
system the ability to remove both tags allows the study of the protein in near native form making
this a novel approach to protein purification compared to other double affinity tag systems.
Once a pure and active helicase has been obtained there are a variety of DNA substrates that
can be used to establish the polarity of unwinding and other DNA unwinding characteristics.
Though not discussed here, synthetic oligonucleotides can also be used to create small
substrates or substrates with unique structures such as forks, bubbles, and Holliday junctions.
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Figure 1. The pTYB4-His-TraI plasmid
Schematic of the pTYB4-His-TraI plasmid with several unique restriction sites noted. The
traI gene is shown in dark blue, the intein-CBD sequence is depicted in cyan, and the 8-His
tag is depicted in red. In addition, the origin of replication (Ori), the ampicillin resistance gene
(AmpR) and the lacI gene are shown.
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Figure 2. A schematic view of purification using pTYB4-His and results from TraI purification
a. Overview of the purification procedure: The fusion protein is bound to a cobalt affinity
column (TALON®) depicted in pink. The protein, including both tags, is eluted from the cobalt
affinity column using an imidazole wash and directly bound to a chitin column depicted in
light grey. After addition of the reducing agent DTT to promote intein-directed cleavage of the
target protein from the affinity tags and incubation at 4°C, the final product is eluted from the
chitin column leaving the intein-CBD-His tag bound to the beads. b. Coomassie blue stained
SDS polyacrylamide gel from a TraI rapid purification. In each lane 5 μg of total protein has
been loaded. Lane 1, crude lysate; lane 2, cleared lysate; lane 3, TALON® flow through; lane
4, TALON® column elution; lane 5, chitin column flow through; and lane 6, chitin elution
containing purified TraI.
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Figure 3. Two circular substrates for helicase assays
a. A 91-mer oligonucleotide is annealed to M13 ssDNA as described in the text. The 3′-end is
extended by two bases using [32P]dCTP and the Klenow fragment of DNA polymerase I to
yield the 93 base pair partial duplex substrate. b. A plasmid containing several Nt.BbvCI sites
is nicked to completion with Nt.BbvCI. The small oligonucleotide fragments are heat denatured
and removed leaving a gapped plasmid. The gap-containing strand is labeled using [32P]dCTP,
dTTP and the Klenow fragment of DNA polymerase I.
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Figure 4. Substrate for determining the directionality of a helicase
A 91-mer oligonucleotide is annealed to M13 ssDNA as described in the text. This partial
duplex DNA is digested with BspDI to generate a linear DNA molecule with double stranded
regions of different length at either end as shown. The overhangs at the end of the DNA are
not drawn to actual size. The resulting overhang ends and the 3′-end of the original
oligonucleotide are filled in or extended using [32P]dCTP, dGTP and the Klenow fragment of
DNA polymerase I to produce the labeled DNA molecule shown.
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